EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression
Main Authors: | C. Antin, A. Tauziède-Espariat, M.-A. Debily, D. Castel, J. Grill, M. Pagès, O. Ayrault, F. Chrétien, A. Gareton, F. Andreiuolo, E. Lechapt, P. Varlet |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-11-01
|
Series: | Acta Neuropathologica Communications |
Online Access: | http://link.springer.com/article/10.1186/s40478-020-01056-8 |
Similar Items
-
Diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma
by: Drew Pratt, et al.
Published: (2020-03-01) -
Autopsy findings of previously described case of diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma
by: Murad Alturkustani, et al.
Published: (2021-06-01) -
PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism
by: Siddhant U. Jain, et al.
Published: (2019-05-01) -
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells
by: Roberta Ragazzini, et al.
Published: (2019-08-01) -
An integrative radiological, histopathological and molecular analysis of pediatric pontine histone-wildtype glioma with MYCN amplification (HGG-MYCN)
by: A. Tauziède-Espariat, et al.
Published: (2019-06-01)